494771-68-5

Basic information

• Product Name: Pyridine, 5-bromo-2-(cyclopentyloxy)-
• Synonyms: 3-Bromo-6-(cyclopentoxy)pyridine;5-Bromo-2-cyclopentyloxypyridine;Pyridine, 5-bromo-2-(cyclopentyloxy)-;2-Chloro-N,N-di-n-propylnicotinaMide, 97%
• CAS NO: 494771-68-5
• Molecular Formula: C₁₀H₁₂BrNO
• Molecular Weight: 242.11
• Mol File: 494771-68-5.mol

Chemical Properties

• Boiling Point: 286.8±20.0 °C(Predicted)
• Appearance: /
• Density: 1.444±0.06 g/cm3(Predicted)
• PKA: 1?+-.0.22(Predicted)
• CAS DataBase Reference: Pyridine, 5-bromo-2-(cyclopentyloxy)-(CAS DataBase Reference)
• NIST Chemistry Reference: Pyridine, 5-bromo-2-(cyclopentyloxy)-(494771-68-5)
• EPA Substance Registry System: Pyridine, 5-bromo-2-(cyclopentyloxy)-(494771-68-5)

Safety Data

• Hazardous Substances Data: 494771-68-5(Hazardous Substances Data)

Upstream product

• 137-43-9 Cyclopentyl bromide 
• 13466-38-1 5-bromopyridin-2(1H)-one 
• 766-11-0 5-bromo-2-fluoropyridine 
• 96-41-3 Cyclopentanol 

Downstream Products

• 871829-85-5 6-cyclopentoxypyridine-3-boronic acid 

Relevant articles and documents

THERAPEUTIC COMPOUNDS

The present embodiments relate to substituted heterocyclic derivative therapeutic compounds, compositions comprising said compounds, and the use of said compounds and compositions for epigenetic regulation by inhibition of bromodomain-mediated recognition

CYCLOALKYLOXY-AND HETEROCYCLOALKYLOXYPYRIDINE COMPOUNDS AS MODULATORS OF THE HISTAMINE H3 RECEPTOR

Certain cycloalkyloxy- and heterocycloalkyloxypyridine compounds are histamine H3 receptor modulators useful in the treatment of histamine H3 receptor-mediated diseases.

TRIAZOLE DERIVATIVES HAVING ANTIFUNGAL ACTIVITY, METHOD FOR THE PREPARATION THEREOF, AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME

A triazole derivative of formula 1 or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof is superior to the conventional antifungal drugs in antifungal activity against a wide spectrum of pathogenic fungi, and has advantageously low toxicity.

INDOLES USEFUL IN THE TREATMENT OF INFLAMMATION

There is provided a compound of formula: (I), wherein X, R1, R2, R3, R4, R5 and R6 have meanings given in the description, and pharmaceutically-acceptable salts thereof, which compounds are useful in the treatment of diseases in which inhibition of the activity of microsomal prostaglandin E synthase-1 is desired and/or required, and particularly in the treatment of inflammation.